MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acs.jnatprod.5c01544

Медицинская библиотека · Journal of natural products · 2026

Activity of Didesmethylrocaglamide in High Grade Serous Ovarian Cancer Using Preclinical In Vitro and In Vivo Models.

Kaweesa Elizabeth N, Benson Nicole, Wilson Tyler A, Addo Ermias Mekuria, Miglo Jane, Bazioli Jaqueline M, Lantvit Daniel D, Agarwal Garima, Kinghorn A Douglas, Fuchs James R, Burdette Joanna E

СтатьяПеревод в очереди

Аннотация

High grade serous ovarian cancer (HGSOC) is the most lethal gynecological cause of death in women and requires new treatments to help tackle chemoresistance. Rocaglamides, a promising class of anticancer natural products, function as protein translation inhibitors and trigger apoptosis in other types of solid tumors. Didesmethylrocaglamide ((±)-DDR), a derivative of rocaglamide with potent antitumor activity, was synthesized, including three additional rocaglamide derivatives, (±)-DDR01, (±)-DDR03, and (±)-DDR04, to evaluate their cytotoxicity in HGSOC. Using in vitro models, it was determined that (±)-DDR induced cytotoxicity in ovarian cancer cell lines as early as 24 h after application and activated caspase-3, indicating pro-apoptotic activity. In addition, (±)-DDR was cytotoxic in the PE04 and MCF7-ADR (OVCAR8-RES) cell lines that are resistant to cisplatin and paclitaxel, respectively. Evaluation of each enantiomer revealed the minus enantiomer to be ∼18-fold more potent compared to the plus enantiomer in the OVCAR8 cell line. (-)-DDR was further evaluated using an OVCAR8 xenograft model in mice, and a reduction in tumor burden was observed. Its effective cytotoxicity in drug-sensitive and -resistant cell models suggests that (±)-DDR and its corresponding minus enantiomer may have potential as a new therapeutic strategy against HGSOC.

Для цитирования: Kaweesa Elizabeth N, Benson Nicole, Wilson Tyler A, Addo Ermias Mekuria, Miglo Jane, Bazioli Jaqueline M, Lantvit Daniel D, Agarwal Garima, Kinghorn A Douglas, Fuchs James R, Burdette Joanna E. Activity of Didesmethylrocaglamide in High Grade Serous Ovarian Cancer Using Preclinical In Vitro and In Vivo Models.. Journal of natural products. 2026. DOI: 10.1021/acs.jnatprod.5c01544.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.